Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2015 1
2016 5
2017 5
2018 2
2019 8
2020 6
2021 8
2022 4
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
Lundgren JR, Janus C, Jensen SBK, Juhl CR, Olsen LM, Christensen RM, Svane MS, Bandholm T, Bojsen-Møller KN, Blond MB, Jensen JB, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS. Lundgren JR, et al. Among authors: svane ms. N Engl J Med. 2021 May 6;384(18):1719-1730. doi: 10.1056/NEJMoa2028198. N Engl J Med. 2021. PMID: 33951361 Clinical Trial.
Emerging drugs for the treatment of obesity.
Martinussen C, Bojsen-Moller KN, Svane MS, Dejgaard TF, Madsbad S. Martinussen C, et al. Among authors: svane ms. Expert Opin Emerg Drugs. 2017 Mar;22(1):87-99. doi: 10.1080/14728214.2017.1269744. Epub 2016 Dec 16. Expert Opin Emerg Drugs. 2017. PMID: 27927032 Review.
Updates in weight loss surgery and gastrointestinal peptides.
Svane MS, Bojsen-Møller KN, Madsbad S, Holst JJ. Svane MS, et al. Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):21-8. doi: 10.1097/MED.0000000000000131. Curr Opin Endocrinol Diabetes Obes. 2015. PMID: 25517025 Review.
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy.
Kjeldsen SAS, Gluud LL, Werge MP, Pedersen JS, Bendtsen F, Alexiadou K, Tan T, Torekov SS, Iepsen EW, Jensen NJ, Richter MM, Goetze JP, Rungby J, Hartmann B, Holst JJ, Holst B, Holt J, Gustafsson F, Madsbad S, Svane MS, Bojsen-Møller KN, Wewer Albrechtsen NJ. Kjeldsen SAS, et al. Among authors: svane ms. iScience. 2023 Oct 12;26(11):108190. doi: 10.1016/j.isci.2023.108190. eCollection 2023 Nov 17. iScience. 2023. PMID: 37953952 Free PMC article.
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Bojsen-Møller KN, Svane MS, Martinussen C, Dirksen C, Jørgensen NB, Jensen JB, Jensen CZ, Torekov SS, Kristiansen VB, Rehfeld JF, Bork-Jensen J, Grarup N, Hansen T, Hartmann B, Holst JJ, Madsbad S. Bojsen-Møller KN, et al. Among authors: svane ms. Int J Obes (Lond). 2023 Nov;47(11):1143-1151. doi: 10.1038/s41366-023-01372-8. Epub 2023 Aug 31. Int J Obes (Lond). 2023. PMID: 37653071 Free PMC article.
Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes.
Skov-Jeppesen K, Christiansen CB, Hansen LS, Windeløv JA, Hedbäck N, Gasbjerg LS, Hindsø M, Svane MS, Madsbad S, Holst JJ, Rosenkilde MM, Hartmann B. Skov-Jeppesen K, et al. Among authors: svane ms. J Clin Endocrinol Metab. 2024 Jan 13:dgae022. doi: 10.1210/clinem/dgae022. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38217866
48 results